Vimarsana
Biggest News Aggregation in the World

Page 16 - Green Pas News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Green Pas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Green Pas Today - Breaking & Trending Today

COVAX Calls For Equal Recognition Of Covid Vaccines For Travel - Vimarsana News

COVAX Calls For Equal Recognition Of Covid Vaccines For Travel

COVAX Calls For Equal Recognition Of Covid Vaccines For Travel COVAX Calls For Equal Recognition Of Covid Vaccines For Travel COVAX -- the global alliance for equitable vaccine distribution -- said it was built on the principle of equitable access to COVID-19 vaccines to protect the health of people all across the globe. The COVAX statement comes as nations begin to re-open travel to vaccinated individuals (File) United Nations: Calling for "equal recognition of vaccines", COVAX on Thursday urged all governments to recognise as "fully vaccinated" those people who have received COVID-19 ...

Source: ndtv.com
Contradictions abound as India seeks EU 'green pass' for Covishield and Covaxin - Vimarsana News

Contradictions abound as India seeks EU 'green pass' for Covishield and Covaxin

: Thursday, July 1, 2021, 9:36 AM IST Contradictions abound as India seeks EU 'green pass' for Covishield and Covaxin - Here's all you need to know Photo: Pixabay Indians looking to travel to European Union nations may face difficulties even if they have been vaccinated against COVID-19. As the 27-nation grouping relaxes travel restrictions under its 'Green Pass' scheme, none of the vaccines presently being administered in India have made it to the list. But as India urges the EU to consider allowing Indians who have taken Covishield and Covaxin vaccines and want to travel to Europe, there a...

Adar Poonawalla Says EU May Clear Covishield In A Month: Matter Of Time - Vimarsana News

Adar Poonawalla Says EU May Clear Covishield In A Month: Matter Of Time

The company has been ramping up its vaccine manufacturing capacities. (File) The Serum Institute of India expects European drug regulators will approve Covishield -- the Covid-19 shot it manufactures in partnership with AstraZeneca Plc -- in a few weeks, paving way for it to be added to the region's 'Green Pass' list. The world's biggest vaccine maker is "quite confident" that the European Medicines Agency will approve the shot in a month, Serum's Chief Executive Office Adar Poonawalla said at the India Global Forum Wednesday. Serum has applied through AstraZeneca, he said, and it was "just a...

Source: ndtv.com
EU Concerns Over Chinese, Russian Jabs May Explain Why Covishield Isn't on 'Green Pass' List - Vimarsana News

EU Concerns Over Chinese, Russian Jabs May Explain Why Covishield Isn't on 'Green Pass' List

EU Concerns Over Chinese, Russian Jabs May Explain Why Covishield Isn't on 'Green Pass' List A source at the external affairs ministry said some EU member-states didn’t want to have people vaccinated with Chinese and Russian vaccines to be travelling to them, so the EU didn't use the WHO-approved list for its 'Green Pass'. A medic shows a vial containing doses of Covishield vaccine during a countrywide inoculation drive against the coronavirus, at BSF Hospital in Jammu, Monday, Jan. 25, 2021. Photo: PTI World29/Jun/2021 New Delhi: The European Union’s plan to roll out its vaccine passp...

Source: thewire.in
Covishield not a 'green pass', Europe-bound Indians fret | India News - Vimarsana News

Covishield not a 'green pass', Europe-bound Indians fret | India News

(Picture for representation) BENGALURU: The exclusion of Covishield, AstraZeneca’s Covid-19 vaccine manufactured by Pune-based Serum Institute of India, from the European Union’s Covid ‘Green Pass’ has left hundreds of Europe-bound students and working professionals confused and helpless. While AstraZeneca’s Vaxzervia is one of four vaccines recognised by the European Medicines Agency (EMA), the same vaccine manufactured in India and distributed under the name Covishield has not been approved. A majority of the more than 2,000 students and working professionals, who got themselves...